Log In
Print
BCIQ
Print
Print this Print this
 

GZ402663, sFLT-01

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionAnti-VEGF chimeric molecules delivered by AAV vectors
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPhase I
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

Partner

Applied Genetic Technologies Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today